MicroRNAs in pancreatic malignancy: progress and promises

Sanjeev K Srivastava1, Sumit Arora1, Seema Singh1

  • 1Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.

Cancer Letters
|February 25, 2014
PubMed
Summary

MicroRNAs (miRNAs) are key players in pancreatic cancer development and resistance to therapy. This review explores their potential as diagnostic, prognostic, and therapeutic tools for this challenging disease.